Goulut-Chassaing C, Bourrillon R
Laboratoire de Biochimie Cellulaire, U.F.R. Biomédicale des Saints-Pères, Paris, France.
Eur J Biochem. 1997 Aug 1;247(3):1091-101. doi: 10.1111/j.1432-1033.1997.01091.x.
In poorly differentiated hepatoma cells, a glycoprotein carrying lactosaminoglycans is identified, and the structure of its glycan moiety is proposed. After membrane solubilization, protein fractionation by gel filtration, and electroelution, this glycoprotein (GPIII) was identified by its affinity for Datura stramonium lectin and its content in large glycopeptides. As shown by PAGE, GPIII has an apparent molecular mass of 100 kDa and is highly glycosylated (36%). It appears as an integral membrane glycoprotein. It is absent from normal hepatocytes, in that no heavy glycopeptides could be detected that bound to Datura lectin or to specific antiserum. The glycan moiety of GPIII has been analyzed according to carbohydrate composition, glycosidase treatment, affinity chromatography on immobilized pokeweed, Datura and Griffonia lectins, and by NMR and methylation analyses. The glycan is a N-linked tetraantennary lactosaminoglycan of 6.6 kDa, containing Gal, GlcNAc, Man, and NeuNAc in a 16:14:3:4 molar ratio, with an average of three repeating units/branch. Its beta-Gal residues are in the penultimate position and are linked in beta1-4 at least in four structural elements (three peripheral and one internal). It contains a very branched structure with Gal alpha1-3Gal beta1-4GlcNAc side chains linked in the C6 position to an inner Gal residue in a main branch. Alpha-Gal and NeuNAc residues [mainly NeuNAc alpha(2-3) linkage] are expressed as the nonreducing terminal groups. A possible structural model is proposed for this heterogeneous lactosaminoglycan, although no definitive structure can be established. That this lactosaminoglycan-carrying glycoprotein GPIII is not expressed in hepatocytes suggests its expression to be linked to the undifferentiated and/or malignant state of this hepatoma.
在低分化肝癌细胞中,鉴定出一种携带乳糖胺聚糖的糖蛋白,并推测了其聚糖部分的结构。经膜溶解、凝胶过滤进行蛋白质分级分离以及电洗脱后,通过该糖蛋白(GPIII)对曼陀罗凝集素的亲和力及其在大糖肽中的含量鉴定出了它。如聚丙烯酰胺凝胶电泳所示,GPIII的表观分子量为100 kDa,且高度糖基化(36%)。它表现为一种整合膜糖蛋白。正常肝细胞中不存在该蛋白,因为未检测到与曼陀罗凝集素或特异性抗血清结合的重糖肽。已根据碳水化合物组成、糖苷酶处理、固定化商陆、曼陀罗和非洲豆蔻凝集素的亲和色谱分析,以及核磁共振和甲基化分析对GPIII的聚糖部分进行了分析。该聚糖是一种6.6 kDa的N-连接四天线乳糖胺聚糖,其半乳糖(Gal)、N-乙酰葡糖胺(GlcNAc)、甘露糖(Man)和唾液酸(NeuNAc)的摩尔比为16:14:3:4,平均每个分支有三个重复单元。其β-半乳糖残基处于倒数第二位,且至少在四个结构元件(三个外周元件和一个内部元件)中以β1-4连接。它含有一个非常分支的结构,其中Galα1-3Galβ1-4GlcNAc侧链在C6位置连接到主分支中的一个内部半乳糖残基上。α-半乳糖和唾液酸残基[主要是NeuNAcα(2-3)连接]作为非还原末端基团存在。尽管无法确定其确切结构,但提出了这种异质性乳糖胺聚糖的一种可能结构模型。这种携带乳糖胺聚糖的糖蛋白GPIII在肝细胞中不表达,这表明其表达与该肝癌的未分化和/或恶性状态有关。